Ken Fisher
AGIO icon

Ken Fisher’s Agios Pharmaceuticals AGIO Stock Holding History

Ken Fisher’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-870,145
Closed -$34.9M – 1020
2025
Q3 		$34.9M Sell
870,145
-7,395
-0.8% -$278K 0.01% 263
2025
Q2 		$29.2M Sell
877,540
-81,799
-9% -$2.48M 0.01% 273
2025
Q1 		$28.1M Sell
959,339
-1,322
-0.1% -$43.9K 0.01% 280
2024
Q4 		$31.6M Buy
960,661
+105,333
+12% +$4.95M 0.01% 286
2024
Q3 		$38M Buy
855,328
+145,416
+20% +$6.6M 0.02% 257
2024
Q2 		$30.6M Buy
709,912
+2,570
+0.4% +$92.8K 0.01% 278
2024
Q1 		$20.7M Sell
707,342
-4,179
-0.6% -$112K 0.01% 332
2023
Q4 		$15.8M Sell
711,521
-105,898
-13% -$2.37M 0.01% 358
2023
Q3 		$20.2M Sell
817,419
-53,680
-6% -$1.42M 0.01% 351
2023
Q2 		$24.7M Buy
871,099
+20,667
+2% +$514K 0.01% 338
2023
Q1 		$19.5M Sell
850,432
-26,521
-3% -$704K 0.01% 368
2022
Q4 		$24.6M Buy
876,953
+37,563
+4% +$1.06M 0.02% 331
2022
Q3 		$23.7M Buy
+839,390
New +$22.5M 0.02% 318

Other funds holding AGIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Ken Fisher's AGIO Position: Q4 2025 in Review

Ken Fisher sold out of Agios Pharmaceuticals (AGIO) in Q4 2025, closing a stake of 870,145 shares — an estimated $34.9M sold.

Ken Fisher first reported a position in AGIO in Q3 2022 and held it in 13 quarters. The position peaked at $38M in Q3 2024. 238 funds tracked by Wall St. Rank hold AGIO as of Q4 2025.

  • Ken Fisher reported no remaining Agios Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Ken Fisher sold 870,145 Agios Pharmaceuticals shares in Q4 2025, an estimated $34.9M.
  • Ken Fisher first reported a position in Agios Pharmaceuticals in Q3 2022 and held it in 13 quarters.
  • Ken Fisher's Agios Pharmaceuticals position peaked at $38M in Q3 2024.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2025.

Based on Fisher Asset Management's 13F filing for Q4 2025, filed 9 Feb 2026.